Patent · US Active

Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use

US8481531B2 · kind B2 · utility

8Cited by

9References

20Claims

0Family size

Assignee

ASTEX THERAPEUTICS LIMITED · GB

Inventors

Gordon Saxty · Cambridge, GB
Valerio Berdini · Cambridge, GB
Eddy Jean Edgard Freyne · Rumst, BE
Alexandra Papanikos · Ekeren, BE
Pascal Benderitter · Embrun, FR
Werner Constant Johan Embrechts · Beerse, BE
Berthold Wroblowski · Vosselaar, BE
Rhalid Akkari · Pantin, FR

Key dates

Filing date	Apr 15, 2010
Grant date	Jul 9, 2013
Priority date	—
Expiry date	Apr 15, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new bicyclic heterocyclyl derivatives of formula (I), to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.